D-amino acid oxidase
D-amino-acid oxidase | |||||||||
---|---|---|---|---|---|---|---|---|---|
ExPASy NiceZyme view | | ||||||||
KEGG | KEGG entry | ||||||||
MetaCyc | metabolic pathway | ||||||||
PRIAM | profile | ||||||||
PDB structures | RCSB PDB PDBe PDBsum | ||||||||
Gene Ontology | AmiGO / QuickGO | ||||||||
|
D-amino-acid oxidase | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Symbol | DAO (DAAO) | ||||||
Chr. 12 q24 | |||||||
|
D-amino acid oxidase (DAAO; also OXDA, DAMOX) is an enzyme with the function on a molecular level to
DAAO is expressed in a wide range of species from yeasts to human.[1] It is not present in plants or in bacteria which instead use D-amino acid dehydrogenase. DAAO in humans is a candidate susceptibility gene[2] and together with G72 may play a role in the glutamatergic mechanisms of schizophrenia.[3] DAAO also plays a role in both biotechnological and medical advancements. Risperidone and sodium benzoate are inhibitors of DAAO.
D-amino acid oxidase is different from diamine oxidase that are both sometimes referred to as DAO.
History
In 1935,
In 1983, inhibitors for the oxidase were discovered. In 2006, the 3D structure of the oxidase was published. Currently, the link between human D-amino acid oxidase (hDAAO) activity and schizophrenia is being researched.[4]
Structure and properties
While D-amino acid oxidase differs to some extent between various
DAO is capable of
Actions in the brain
DAO acts in the brain to oxidize specific D-amino acids using the FAD region (flavin adenine dinucleotide region) and is commonly thought to be produced in the hindbrain, although there is new evidence of DAO expression in the forebrain as well.[6] The DAO present in the forebrain seems to be inactive, however, causing speculation on the topic of DAO function in the forebrain as opposed to the hindbrain where the function is more well-known.[6] The consensus is that DAO is produced and is active in glial cells, most specifically in cerebellar type-1 and type-2 astrocytes,[1] and the D-serine amino acid that is produced by DAO in these cells has been shown to increase synaptic NMDA receptor activity.[1]
Impact on schizophrenia
There is evidence to show that schizophrenia, as a neural phenomenon, is associated with both hyper- and hypoglutamatergic function, mediated by NMDA receptors.[7] Dysfunction of NMDA receptors, and the corresponding hypoglutamatergic signaling, produces overstimulation ionotropic receptors and leads to excitotoxicity.[8]
It has been shown that decreased DAO activity leads to an increase in NMDA activity in the hypothalamus .[1] Inhibition of DAO leads to the increase of D-serine levels which act as agonists at the NMDAR.[8]
A study confirmed the increased NMDA activity and showed increased DAO activity in the cerebellum of schizophrenia subjects.[6] The genetic background of DAO involvement in schizophrenia is highly debated, and no compulsatory evidence has been found for DAO genes being strongly linked to schizophrenia. Although, the G72 gene, which reportedly encodes the D-amino acid oxidase activator, may be involved in the development of schizophrenia.[6]
Regulation
Bassoon protein
Additionally, researchers focused on compounds that could act as hDAAO inhibitors. Over 500 different compounds have been observed in vitro/in vivo to act as inhibitors on the oxidase and most of them do by
Applications
Biotechnology
Cephalosporin synthesis
D-amino acid oxidase is used in
D-amino acid biosensor
D-amino acid oxidase reacts to D-amino acids and can be used to detect the amount of D-amino acids in foods to act as a biosensor. This is important due to the effects of D-amino acids in the D-isomer or multiple enantiomers present in food has on the nutritional value. The more D-isomer or multiple enantiomers present in food, the lower the nutritional value of the food is, so using D-amino acid oxidase to detect these allows for an increase in selection for nutritionally valuable foods.[12] There is no evidence to prove that D-amino acids are toxic, but it raises many possible concerns whether some foods are toxic.
Medical
Cancer treatment
RgDAAO is used in a process called
Therapeutic treatments
D-amino acid oxidase is used in therapeutic treatments such as regulation of hormones, regulation of
See also
- DAOA-AS1
- D-amino acid dehydrogenase
- D-amino acid oxidase activator
- D-aspartate oxidase
- Diamine oxidase
External links
- D-Amino-Acid+Oxidase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- http://www.calzyme.com/commerce/catalog/spcategory.jsp?category_id=1043
References
- ^ S2CID 24070769.
- ^ SZGene database (28 August 2007). "Gene Overview of All Published Schizophrenia-Association Studies for DAAO". Schizophrenia Research Forum. Archived from the original on 2008-05-12.
- S2CID 24756346.
- ^ a b "Amino Acid Oxidase, D-". Worthington Biochemical Corporation. Retrieved 26 March 2018.
- ^ PMID 29250527.
- ^ PMID 19786963.
- PMID 10628529.
- ^ PMID 18922967.
- ^ "BSN - Protein bassoon - Homo sapiens (Human) - BSN gene & protein". www.uniprot.org.
- PMID 29417050.
- ^ S2CID 12644310.
- ^ S2CID 18587080.
- PMID 20648222.)
{{cite journal}}
: CS1 maint: DOI inactive as of March 2024 (link